IX Biopharma Company Announcements (42C)

SGX Google Yahoo News TradingView

IX BIOPHARMA LTD. (42C) SGD 0.024 +0.00% +0.00

Portfolio Watchlist

All Financial Buy Back Insider Trading

2018-09-21

General Announcement::UPDATE ANNOUNCEMENT ON PROPOSED SILDENAFIL RECLASSIFICATION

2018-09-05

General Announcement::IX BIOPHARMA REPORTS POSITIVE RESULTS FROM WAFERMINE PHASE 2 MULTI-DOSE CLINICAL EFFICACY TRIAL

2018-08-27

Financial Statements and Related Announcement::Full Yearly Results

2018-08-06

General Announcement::APPROVAL OF FIRST CAPSULE SILDENAFIL DRUG FOR TREATMENT OF MALE ERECTILE DYSFUNCTION IN AUSTRALIA

2018-06-25

General Announcement::CHANGE IN USE OF IPO PROCEEDS

2018-06-19

General Announcement::IX BIOPHARMA OBTAINS APPROVAL & REGISTRATION OF WAFESIL FOR TREATMENT OF MALE ERECTILE DYSFUNCTION

2018-06-12

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2018-05-09

Financial Statements and Related Announcement::Third Quarter Results

2018-04-18

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2018-04-18

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2018-04-05

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2018-03-12

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2018-03-08

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang

2018-02-08

General Announcement::IX BIOPHARMA SECURES CHINA PATENT FOR WAFERIX DRUG DELIVERY TECHNOLOGY

2018-02-08

Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results

2018-01-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2018-01-04

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2017-11-20

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2017-11-10

Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

2017-11-10

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification in Respect of Changes in Interest of a Director - Eddy Lee Yip Hang

2017-11-10

Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN

2017-11-08

General Announcement::Establishment of A Risk Management Committee

2017-11-08

Financial Statements and Related Announcement::First Quarter Results

2017-10-24

General Announcement::Responses to SIAS' Questions on iX Biopharma's Annual Report FY2017

2017-10-24

REPL::Extraordinary/ Special General Meeting::Voluntary

2017-10-24

REPL::Annual General Meeting::Voluntary

2017-10-23

General Announcement::iX Biopharma Secures European Patent for WaferiX Drug Delivery Technology

2017-09-27

Extraordinary/ Special General Meeting::Voluntary

2017-09-27

Annual Reports and Related Documents::

2017-09-27

Annual General Meeting::Voluntary

2017-08-23

Financial Statements and Related Announcement::Full Yearly Results

2017-05-15

General Announcement::iX Biopharma Launches New Supplements Business Arm

2017-05-14

General Announcement::iX Biopharma Reports Positive Results from Pharmacokinetic Study of BnoX

2017-05-11

Financial Statements and Related Announcement::Third Quarter Results

2017-02-10

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2017-02-08

Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results

2016-12-29

Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO iX PERFORMANCE SHARE PLAN

2016-11-21

General Announcement::iX Biopharma Secures South African Patent for Waferix Drug Delivery Technology

2016-11-15

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-11-11

Financial Statements and Related Announcement::First Quarter Results

2016-10-31

General Announcement::iX Biopharma Secures Canadian Patent for WaferiX Drug Delivery Technology

2016-10-25

General Announcement::Responses to SIAS' Questions on iX Biopharma's Annual Report FY2016

2016-10-25

REPL::Annual General Meeting::Voluntary

2016-10-05

Annual Reports and Related Documents::

2016-10-05

Annual General Meeting::Voluntary

2016-10-04

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification in Respect of Changes in Interest of a Director - Eddy Lee Yip Hang

2016-09-30

Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

2016-09-13

General Announcement::iX Biopharma Announces Positive Results from Pivotal Study of Erectile Dysfunction Drug

2016-08-25

Financial Statements and Related Announcement::Full Yearly Results

2016-08-17

General Announcement::iX Biopharma Announces Development of Supplement for Jet Lag

© 2024 Dividends.sg / More Countries

© Owned by Little White Pte. Ltd.